Professor Andrew M Bellizzi, M.D.
University of Iowa Hospitals and Clinics
2024 Endocrine Pathology COURSE INFORMATION
The focal point for the 2024 Banff Course is Endocrine Pathology. This course serves as a platform for exchanging insights into the latest advancements in the field. It will cover topics crucial for practicing pathologists and trainees, encompassing comprehensive discussions on thyroid, parathyroid, pancreas, adrenal, and endocrine lesions from other sites. Renowned experts from around the globe will deliver in-depth presentations, shedding light on various aspects relevant to Endocrine Pathology, with a primary emphasis on diagnosis, including updates on nomenclature, new entities and upcoming molecular tests. Additionally, the course will spotlight pertinent aspects related to the prognosis and management of endocrine tumours and conditions, offering insights into the evolving landscape of treatment strategies and prognostic markers that may relate to the practice of pathologists.
Target Audience
This course is tailored for practicing general and anatomic pathologists, pathologist assistants, endocrine surgeons, clinicians specializing in endocrinology and oncology, as well as residents and fellows pursuing training in any of these specialties.
OBJECTIVES:
Upon completion of this course, participants will be equipped to:
- Assess and apply recent updates in endocrine pathology.
- Identify and address complex thyroid, parathyroid, lung, GI, pancreas, and adrenal pathology lesions.
- Demonstrate proficiency in utilizing immunohistochemistry markers to ascertain tumour diagnosis, origin and prognosis with relevant clinical, radiological and surgical correlations
- Recognize the significance of molecular pathology in understanding and diagnosing endocrine pathology conditions.
- Navigate challenges associated with nomenclature in lung endocrine tumours.
- Discuss genetic syndromes relevant to endocrine pathology and their diagnostic implications.
- Engage in case presentations and discussion of current topics in endocrine pathology
COMMITTEE INFORMATION:
Course Directors:
Dr. Benjamin Adam
Dr. Michael Mengel
Dr. Dylan Pillai
Planning Committee Co-Chairs:
Dr. Julinor Bacani
Dr. Steven Gorombey
Planning Committee Members:
Dr. Marcia Abbott
Dr. Erin Chapman
Dr. Konstantin Koro
Dr. Remegio Maglantay
Dr. Sebastiao Martins
Dr. Adrian Sim
Dr. Emilija Todorovic
Sponsor Showcase
Platinum Sponsor
At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy DNA and RNA sequence data in studies around the globe. Our microarrays also provide accurate, high-throughput genotyping for a range of applications. Through innovation and collaboration, we have developed comprehensive genomic profiling tools that help investigators identify biomarkers, describe tumor biology, and inform therapy selections. The opportunity to transform tumor profiling with innovative assays, new companion diagnostics, and liquid biopsy tools inspires us to push the boundaries of what is possible and drive innovation.
Gold Sponsor
At Bayer, we are committed to delivering “Science for a better life” by advancing a portfolio of innovative treatments. Oncology research at Bayer is focused on developing new cancer treatments and making them available to patients who need them all over the world. Our pipeline explores specific treatment approaches for various tumours, including those found in the prostate, lung, ovaries and bladder as well as some rarer forms of cancer (for ex. tumour agnostic treatments). Our Canadian Precision Oncology team is also focused on a vision of collaborating with our healthcare partners to improve equities in comprehensive genomic profiling and access to targeted treatments in all solid tumours.
Speaker Highlights
Professor William C. Faquin, MD, PhD
Harvard Medical School
Massachusetts Eye and Ear Infirmary
Professor Anthony J. Gill AM MD FRCPA
University of Sydney
Royal North Shore Hospital
DISCLOSURE OF POTENTIAL FINANCIAL CONFLICTS OF INTEREST
In keeping with accreditation guidelines, speakers participating in this event have been asked to disclose to the audience any financial involvement with industry or other organizations that may potentially influence the presentation of the educational material. Disclosure may be done verbally or using a slide prior to the speaker’s presentation.
FREEDOM OF INFORMATION & PROTECTION OF PRIVACY (FOIPP) ACT
The registration information is collected under the authority of the Alberta FOIPP Act. This information is required to register you in the course, prepare the course material for your use, and will be used to notify you of other courses or pertinent information. The financial information is used to process applicable fees and is retained for future reference. This information will not be shared with any other individual or organization.